Interleukin‐8 promoter polymorphism is associated with the initial repose to bevacizumab in AMD treatmentIlkka Immonen,A Hautamaki,J M Kivioja, S Vavuli,Sakari Kakko,Er Savolainen,Markku J Savolainen,J Liinamaa,S Seitsonen,Paivi Onkamo,Irma JarvelaActa Ophthalmologica(2013)引用 4|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要